Left ventricular hypertrophy and arrhythmogenesis

Area of Science:

• Cardiology
• Cardiovascular Medicine
• Medical Diagnostics

Background:

• Left ventricular hypertrophy (LVH) is a significant independent risk factor for cardiovascular morbidity and mortality.
• LVH is associated with serious complications such as atrial and ventricular arrhythmias, and sudden cardiac death.
• Hypertension and valvular heart disease are the primary etiological factors contributing to LVH.

Purpose of the Study:

• To outline the diagnostic approaches for LVH.
• To emphasize the importance of etiology-based management for LVH.
• To highlight the benefits of timely and optimal intervention in LVH regression and complication reduction.

Main Methods:

• Initial diagnosis and therapy evaluation commonly utilize electrocardiography and echocardiography.
• Cardiac Magnetic Resonance (CMR) imaging is considered the gold standard for LVH diagnosis and assessing therapeutic response.
• Management strategies are guided by the underlying etiology, current evidence, and established clinical guidelines.

Main Results:

• Early detection and appropriate management of LVH are crucial for patient outcomes.
• Addressing the root causes of LVH leads to regression of the condition.
• Effective management reduces the incidence of associated arrhythmias and sudden cardiac death.

Conclusions:

• LVH necessitates prompt and accurate diagnosis and management.
• Personalized treatment strategies based on etiology and evidence improve LVH regression.
• Optimal management of LVH significantly mitigates associated cardiovascular risks, enhancing patient survival and quality of life.